Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

In a significant breakthrough, scientists at Johns Hopkins University have discovered that gene therapy could be a key to forcing HIV into a permanent dormant state, potentially offering a long-term, ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

While promising, a recent breakthrough in HIV research is not a “cure” or a “vaccine”, as several posts claim on social media ...

The national rollout program continues to expand, with more vending machines to be installed in Australian universities, in NSW, South Australia and Victoria. Vending machines have also been rolled ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The drug nearly eliminated HIV's spread among people who received an injection every six months. But some experts worry about how accessible it will be.